Class Action Cases

Join the case to recover your losses. Click "Join this Class Action" above.

Attorneys

Veru Inc.

Join Class Action »

According to the Complaint, the Company made false and misleading statements to the market. Veru failed to disclose to the market adverse facts found in the data related to its VERU-111 Phase 3 trial and its communications with the FDA. The Company led investors to believe that its trial supported Emergency Use Authorization (“EUA”) and the submission of an New Drug Application (“NDA”) without additional studies, which was not likely to be true. The Company failed to share the true risks of receiving EUA approval based on the Phase 3 trial. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Veru, investors suffered damages.

Press Release

SHAREHOLDER ACTION ALERT: The Schall Law Firm Files Class Action on Behalf of Investors in Veru Inc. and Advises Shareholders with Losses of $100,000 to Contact the Firm

Los Angeles, December 6, 2022 — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Veru Inc. (“Veru” or “the Company”) (NASDAQ: VERU) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company’s securities between May 11, 2022 and November 9, 2022, inclusive (the ”Class Period”), are encouraged to contact the firm before February 3, 2023.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at bschall@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Veru failed to disclose to the market adverse facts found in the data related to its VERU-111 Phase 3 trial and its communications with the FDA. The Company led investors to believe that its trial supported Emergency Use Authorization (“EUA”) and the submission of an New Drug Application (“NDA”) without additional studies, which was not likely to be true. The Company failed to share the true risks of receiving EUA approval based on the Phase 3 trial. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Veru, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com

Office: 310-301-3335

info@schallfirm.com

 

SOURCE:

The Schall Law Firm

Cases

  • Drop files here or
    Accepted file types: xls, xlsx, doc, pdf, jpg, jpeg, Max. file size: 32 MB, Max. files: 5.
      You may redact your account numbers from your uploaded documents. The Schall Law Firm is committed to protecting the privacy of confidential information. Your documents will be securely held in AWS S3 and will only be used as proof of your transactions in connection with this matter.
    • Purchases
      MM slash DD slash YYYY
      If fractional shares, please round to the nearest whole number.
    • Sales
      MM slash DD slash YYYY
    • By submitting your information, you acknowledge that this form does not create an attorney-client relationship between yourself and The Schall Law Firm. Any information you submit will be maintained as confidential. The Schall Law Firm, in its sole discretion, will contact you if it requires further information from you.